(Q43719049)

English

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study

scientific article published in July 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

J B Vermorken

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

G Zanetta

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

C F De Oliveira

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

M E van der Burg

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A J Lacave

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

I Teodorovic

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

G H Boes

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

N Colombo

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

967-974

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer of the Uterine Cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in squamous cell carcinoma of the cervix uteri: Present role and perspectives

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in recurrent and advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Single agent versus combination chemotherapy in recurrent cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011165115426

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1011165115426

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43719049&oldid=2102812214"